GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Krka d.d. (XLJU:KRKG) » Definitions » Cyclically Adjusted Revenue per Share

Krka d.d. (XLJU:KRKG) Cyclically Adjusted Revenue per Share : €52.70 (As of Sep. 2023)


View and export this data going back to 1997. Start your Free Trial

What is Krka d.d. Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Krka d.d.'s adjusted revenue per share for the three months ended in Sep. 2023 was €13.578. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €52.70 for the trailing ten years ended in Sep. 2023.

During the past 12 months, Krka d.d.'s average Cyclically Adjusted Revenue Growth Rate was 6.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2024-06-06), Krka d.d.'s current stock price is €131.00. Krka d.d.'s Cyclically Adjusted Revenue per Share for the quarter that ended in Sep. 2023 was €52.70. Krka d.d.'s Cyclically Adjusted PS Ratio of today is 2.49.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Krka d.d. was 2.66. The lowest was 1.73. And the median was 2.17.


Krka d.d. Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Krka d.d.'s Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Krka d.d. Cyclically Adjusted Revenue per Share Chart

Krka d.d. Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 45.80 49.90

Krka d.d. Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 49.65 49.90 51.07 51.92 52.70

Competitive Comparison of Krka d.d.'s Cyclically Adjusted Revenue per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Krka d.d.'s Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Krka d.d.'s Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Krka d.d.'s Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Krka d.d.'s Cyclically Adjusted PS Ratio falls into.



Krka d.d. Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Krka d.d.'s adjusted Revenue per Share data for the three months ended in Sep. 2023 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Sep. 2023 (Change)*Current CPI (Sep. 2023)
=13.578/129.8595*129.8595
=13.578

Current CPI (Sep. 2023) = 129.8595.

Krka d.d. Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201312 10.429 98.326 13.774
201403 9.107 99.695 11.863
201406 9.165 100.560 11.835
201409 8.047 100.428 10.405
201412 10.012 99.070 13.124
201503 8.871 99.621 11.564
201506 9.558 100.684 12.328
201509 8.051 100.392 10.414
201512 9.307 99.792 12.111
201603 9.297 100.470 12.017
201606 9.328 101.688 11.912
201609 7.696 101.861 9.811
201612 9.909 101.863 12.632
201703 9.929 102.862 12.535
201706 10.367 103.349 13.026
201709 8.465 104.136 10.556
201712 10.555 104.011 13.178
201803 10.515 105.290 12.969
201806 10.716 106.317 13.089
201809 9.086 106.507 11.078
201812 11.311 105.998 13.857
201903 12.039 107.251 14.577
201906 12.192 108.070 14.650
201909 10.519 108.329 12.610
201912 12.250 108.420 14.672
202003 14.702 108.902 17.531
202006 10.837 108.767 12.939
202009 11.371 109.815 13.447
202012 11.967 109.897 14.141
202103 12.671 111.754 14.724
202106 13.217 114.631 14.973
202109 11.836 115.734 13.281
202112 12.482 117.630 13.780
202203 13.922 121.301 14.904
202206 13.655 125.017 14.184
202209 12.378 125.227 12.836
202212 15.323 125.222 15.891
202303 14.773 127.348 15.064
202306 14.960 128.729 15.091
202309 13.578 129.860 13.578

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Krka d.d.  (XLJU:KRKG) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Krka d.d.'s Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=131.00/52.7
=2.49

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Krka d.d. was 2.66. The lowest was 1.73. And the median was 2.17.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Krka d.d. Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Krka d.d.'s Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Krka d.d. (XLJU:KRKG) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Krka d.d. (XLJU:KRKG) » Definitions » Cyclically Adjusted Revenue per Share
Traded in Other Exchanges
Address
Smarjeska Cesta 6, Novo Mesto, SVN, 8501
Krka d.d. engages in the development, production, marketing, and sales of human health products (prescription pharmaceuticals and non-prescription products), animal health products, health resort, and tourist services. The company products in Prescription pharmaceuticals include Cardiovascular diseases, Infections, Oncology; Non-prescription products include Cold and cough products, nasal products, vitamin and minerals, hair care products; and Animal health products include Antimicrobials, Disinfectants, among others. It operates across the European Union, South-East Europe, East Europe region, and Others. The company derives a majority of revenue from the European Union.

Krka d.d. (XLJU:KRKG) Headlines

No Headlines